Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STAAR SURGICAL CO Director's Dealing 2014

Mar 12, 2014

31996_dirs_2014-03-11_f9a824d6-f91b-4097-b774-77cad81c4df5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2014-03-07

Reporting Person: Francese James E (VP, Global Marketing)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-03-07 Common Stock A 7000 Acquired 14500 Direct
2014-03-07 Common Stock A 12000 Acquired 26500 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-03-07 Common Stock Options $15.54 A 15000 Acquired 2024-03-06 Common Stock (15000) Direct

Footnotes

F1: Consists of 7,000 Restricted Shares of Common Stock (RSU), subject to forfeiture rights, which lapses as to 1/2 of the shares (3500 shares) on 3/7/16 and lapses as to the other 1/2 of the shares (3500 shares) on 3/7/17.

F2: Consists of 7,500 PARS.

F3: The options first become exercisable as follows: 5,000 shares on 3/7/15, 5,000 shares on 3/7/16 and 5,000 shares on 3/7/17.

F4: Consists of 12,000 performance-contingent restricted shares pursuant to the 2013 RSU Plan which vested on 3/7/2014.